FDA Inspection 1076519 — KLEB Inc
The FDA completed an inspection of KLEB Inc on Dec 19, 2018 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 19, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lexington, KY (United States)